Additionally, regulatory pathways frequently altered in various cancers were examined, such as increased expression of the cyclin inhibitor p21 (six articles) and decreased activation of the AKT pathway (five articles), leading to reduced cell proliferation and survival. This evidence concerns the gene AKT1 and cancer.